Decoding the role of Azelastine and Fluticasone Furoate Fixed Dose Combination Spray in Management of Allergic Rhinitis Dr. Kamal Kant Kohli4 Jan 2023 11:15 AM ISTAllergic rhinitis (AR) is a widespread disease that affects approximately 400 million people globally, and its incidence has risen over time, posing a...
Unfolding Allergic Rhinitis and Asthma Link: Reviewing Role of Intranasal Spray in Pediatric Patients Dr. Kamal Kant Kohli24 Dec 2022 10:45 AM ISTWith a prevalence of up to 50% across nations, allergic rhinitis (AR) is among the most prevalent immunologically mediated allergic diseases...
Air Pollution and Allergic Rhinitis-Interactions, Effects, and Intervention Needs Dr. Kamal Kant Kohli16 Nov 2022 12:46 PM ISTAllergic rhinitis (AR) is an IgE-mediated type 1 hypersensitivity illness. It is aggravated by environmental allergens such as pollen (primarily from...
United Airway Disease and Clinical Applicability of Montelukast Fexofenadine Combination: Review Dr. Kamal Kant Kohli20 Oct 2022 12:30 PM ISTRecent epidemiological, pathophysiological, and clinical scientific evidence has identified a relationship between upper and lower respiratory...
Respiratory Allergies in India and Clinical Review of Montelukast Fexofenadine Combination in its Management Dr. Kamal Kant Kohli24 Sept 2022 11:57 AM ISTAllergic respiratory diseases (ARDs) are caused by the production of IgE antibodies to airborne allergens, causing various clinical manifestations in...
Allergic Rhinitis in Children: Practitioners Update and Consideration for Use of Intranasal Fluticasone Based Therapies Dr. Kamal Kant Kohli23 Aug 2022 12:45 PM ISTAllergic rhinitis (AR), an inflammatory disease caused by an IgE-mediated immune response to inhaled allergens, is a frequently occurring childhood...
Management of Allergic Rhinitis during COVID-19 Pandemic Dr. Kamal Kant Kohli27 Jun 2022 12:00 PM ISTThe COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) has challenged the healthcare systems and altered the...
Novel therapies in managing Allergic rhinitis: How far have we come? Dr. Kamal Kant Kohli8 Jun 2022 12:45 PM ISTAllergic rhinitis(AR) is a common respiratory condition affecting 40 % of the worldwide population. Due to its shared pathophysiology with...
Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable connection Dr. Kamal Kant Kohli19 May 2022 12:54 PM ISTThe spiking frequency of allergic respiratory illness over the last several decades, and the increasing rate of air pollution owing to urbanization,...
